Governmental authorities increasingly focused on economics, growing competition by generics, the implementation of rebate contracts, networks of doctors and an increasing deficits in public health care budgets: these are only a few of the changes that are forcing the pharma industry to develop new strategies not only in research & development but also for sales […]

Read more